Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check36 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. This is a minor update that does not affect the displayed study details or workflow.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check109 days agoChange DetectedAdded new study locations in Canada (Nova Scotia and Quebec) under the Locations section. The HHS Vulnerability Disclosure link was removed from the footer as part of the v3.3.3 update.SummaryDifference0.3%

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.